Literature DB >> 18444217

Electrode implantation for deep brain stimulation in dystonia: a fast spin-echo inversion-recovery sequence technique for direct stereotactic targeting of the GPI.

M O Pinsker1, J Volkmann, D Falk, J Herzog, K Alfke, F Steigerwald, G Deuschl, M Mehdorn.   

Abstract

OBJECTIVE: Deep brain stimulation (DBS) of the globus pallidus internus (GPi) is an effective treatment for medically refractory primary dystonia. We present our technique for direct preoperative visualization of the target using a fast spin-echo inversion-recovery (FSE-IR) sequence.
METHODS: Twenty-three consecutive patients (mean age 41 years, range 9-68 years, male to female ratio 11:12) with severe dystonia were operated using a combination of FSE-IR imaging for direct visualization of the globus pallidus internus with stereotactic, gadolinium-enhanced T1-MPRage images. The complete procedure, including stereotactic MRI, was performed under general anesthesia with propofol and remifentanyl. We used multichannel microdrive systems (Medtronic; Alpha-Omega) to introduce up to five parallel microelectrodes for microelectrode recordings (MER) and test stimulation with the central trajectory directed at the anatomically predefined target. The initial standard coordinates in relation to the mid-commissural point (mid-AC-PC) were as follows: lateral 21 mm, anterior 3 mm, and inferior 2 mm, which were then adapted to the individual case based on direct visualization of the target area and further refined by the intraoperative neurophysiology.
RESULTS: In ten patients (43%) atlas-based standard coordinates were modified based on the direct visualization of the GPi in the FSE-IR images (bilaterally in seven patients, unilaterally in three). The modified targets ranged from 18.5 to 23.5 mm (mean 20.76 mm) laterally, 1-7 mm (mean 2.75 mm) anteriorly and 1-2 mm (mean 1.95 mm) inferiorly to the mid-AC-PC. We implanted the permanent electrode based on the results of MER and intraoperative stimulation performed to determine the threshold for pyramidal tract responses on the central trajectory in 67%, medially in 16%, anteriorly in 11%, laterally in 4%, dorsally in 2%. The procedure resulted in excellent clinical benefits (average reduction of the Burke-Fahn-Marsden Dystonia Rating Score (BFMDRS) or the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) were respectively 65.9%, range 20.9-91.4%) within the first year after surgery. Safety was demonstrated by the absence of intracranial bleeding or other surgical complications causing neurological morbidity.
CONCLUSION: Inversion recovery sequences are an excellent tool for direct visualization of the GPi. These images can be fused to stereotactic MRI or CCT and may help to improve anatomical targeting of the GPi for the implantation of DBS electrodes.

Entities:  

Mesh:

Year:  2008        PMID: 18444217     DOI: 10.1055/s-2007-1004583

Source DB:  PubMed          Journal:  Zentralbl Neurochir        ISSN: 0044-4251


  11 in total

1.  Optimal MRI methods for direct stereotactic targeting of the subthalamic nucleus and globus pallidus.

Authors:  Ruth L O'Gorman; Karin Shmueli; Keyoumars Ashkan; Michael Samuel; David J Lythgoe; Asal Shahidiani; Stephen J Wastling; Michelle Footman; Richard P Selway; Jozef Jarosz
Journal:  Eur Radiol       Date:  2010-07-21       Impact factor: 5.315

Review 2.  Stereotactic implantation of deep brain stimulation electrodes: a review of technical systems, methods and emerging tools.

Authors:  Simone Hemm; Karin Wårdell
Journal:  Med Biol Eng Comput       Date:  2010-06-02       Impact factor: 2.602

3.  [Neurosurgical standards in deep brain stimulation : consensus recommendations of the German Deep Brain Stimulation Association].

Authors:  J Voges; K Kiening; J K Krauss; G Nikkhah; J Vesper
Journal:  Nervenarzt       Date:  2009-06       Impact factor: 1.214

Review 4.  Dystonia rating scales: critique and recommendations.

Authors:  Alberto Albanese; Francesca Del Sorbo; Cynthia Comella; H A Jinnah; Jonathan W Mink; Bart Post; Marie Vidailhet; Jens Volkmann; Thomas T Warner; Albert F G Leentjens; Pablo Martinez-Martin; Glenn T Stebbins; Christopher G Goetz; Anette Schrag
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

5.  Full Parkinsonian Triad Induced by Pallidal High-Frequency Stimulation in Cervical Dystonia.

Authors:  René Reese; Alfonso Fasano; Karina Knudsen; Jan Herzog; Daniela Falk; Hubertus Maximilian Mehdorn; Günther Deuschl; Jens Volkmann
Journal:  Mov Disord Clin Pract       Date:  2014-11-04

6.  A pooled meta-analysis of GPi and STN deep brain stimulation outcomes for cervical dystonia.

Authors:  Takashi Tsuboi; Joshua K Wong; Leonardo Almeida; Christopher W Hess; Aparna Wagle Shukla; Kelly D Foote; Michael S Okun; Adolfo Ramirez-Zamora
Journal:  J Neurol       Date:  2020-01-14       Impact factor: 4.849

Review 7.  [Deep brain stimulation for treatment of dystonia and tremor].

Authors:  L Timmermann; J Volkmann
Journal:  Nervenarzt       Date:  2010-06       Impact factor: 1.214

8.  The optimal pallidal target in deep brain stimulation for dystonia: a study using a functional atlas based on nonlinear image registration.

Authors:  Christopher Tolleson; Srivatsan Pallavaram; Chen Li; John Fang; Fenna Phibbs; Peter Konrad; Peter Hedera; Pierre-François D'Haese; Benoit M Dawant; Thomas L Davis
Journal:  Stereotact Funct Neurosurg       Date:  2014-12-09       Impact factor: 1.875

Review 9.  Efficacy and safety of general anesthesia deep brain stimulation for dystonia: an individual patient data meta-analysis of 341 cases.

Authors:  Jia-Jing Wang; Han Tian; Jing Rao; Nian Xiong; Dong-Ye Yi; Xiao-Ming Liu; Wei Xiang; Hong-Yang Zhao; Xiao-Bing Jiang; Peng Fu
Journal:  Neurol Sci       Date:  2021-04-14       Impact factor: 3.307

10.  Using MDEFT MRI Sequences to Target the GPi in DBS Surgery.

Authors:  Andreas Nowacki; Michael Fiechter; Jens Fichtner; Ines Debove; Lenard Lachenmayer; Michael Schüpbach; Markus Florian Oertel; Roland Wiest; Claudio Pollo
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.